Noriyoshi Iriyama

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Topics

Newly Diagnosed

Tyrosine Kinase

Diffuse Large B Cell Lymphoma

Chronic Myeloid Leukemia

Top Venues

International journal of hematology

Medical oncology (Northwood, London, England)

Hematological oncology

Clinics and practice

This page only lists publications with an associated author ORCID identifier.

Publications

Noriyoshi Iriyama, Eisaku Iwanaga, Yuta Kimura, Naoki Watanabe, Maho Ishikawa, Hitomi Nakayama, Eriko Sato, Takayuki Tabayashi, Toru Mitsumori, Tomoiku Takaku, Tomonori Nakazato, Michihide Tokuhira, Hiroyuki Fujita, Miki Ando, Yoshihiro Hatta, Tatsuya Kawaguchi
Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi-institutional retrospective study by the CML Cooperative Study Group. International journal of hematology (2024)
Noriyoshi Iriyama, Eisaku Iwanaga, Yuta Kimura, Naoki Watanabe, Maho Ishikawa, Hitomi Nakayama, Eriko Sato, Takayuki Tabayashi, Toru Mitsumori, Tomoiku Takaku, Tomonori Nakazato, Michihide Tokuhira, Hiroyuki Fujita, Miki Ando, Yoshihiro Hatta, Tatsuya Kawaguchi
Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi-institutional retrospective study by the CML Cooperative Study Group. International journal of hematology 120 (1) (2024)
Itaru Matsumura, Shigeki Ohtake, Yoshiko Atsuta, Mio Kurata, Yosuke Minami, Naoto Takahashi, Chiaki Nakaseko, Noriyoshi Iriyama, Katsumichi Fujimaki, Kazuhiko Kakihana, Yoji Ogasawara, Takaaki Ono, Masaya Okada, Tetsuzo Tauchi, Toshihiro Miyamoto, Kazunori Ohnishi, Emiko Sakaida, Shin Fujisawa, Yukio Kobayashi, Norio Asou, Tomoki Naoe, Hitoshi Kiyoi, Yasushi Miyazaki
Nilotinib vs. Dasatinib in Achieving MR4.5 for de novo Chronic Myeloid Leukemia: the Randomized JALSG CML212 Study. Blood advances (2024)
Hiroshi Ureshino, Yusuke Takeda, Kazuharu Kamachi, Takaaki Ono, Noriyoshi Iriyama, Eiichi Ohtsuka, Emiko Sakaida, Shinya Kimura
A Higher Neutrophil Count Is Associated with Favorable Achievement of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Who Received Second Generation Tyrosine Kinase Inhibitor as Frontline Treatment. Clinics and practice 14 (4) (2024)
Hiroshi Ureshino, Yusuke Takeda, Kazuharu Kamachi, Takaaki Ono, Noriyoshi Iriyama, Eiichi Ohtsuka, Emiko Sakaida, Shinya Kimura
A Higher Neutrophil Count Is Associated with Favorable Achievement of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Who Received Second Generation Tyrosine Kinase Inhibitor as Frontline Treatment. Clinics and practice 14 (4) (2024)
Hiromichi Takahashi, Katsuhiro Miura, Masaru Nakagawa, Haruna Nishimaki, Shun Ito, Hironao Nukariya, Kazuya Kurihara, Toshihide Endo, Takashi Koike, Takashi Hamada, Kazuhide Iizuka, Shimon Ohatake, Noriyoshi Iriyama, Tomohiro Nakayama, Shinobu Masuda, Yoshihiro Hatta, Hideki Nakamura
Pirarubicin-based intensive chemotherapy followed by consolidative high-dose chemotherapies for peripheral T-cell lymphomas: A noncomparative phase 2 study. Hematological oncology (2022)
Noriyoshi Iriyama, Katsuhiro Miura, Hiromichi Takahashi, Masaru Nakagawa, Kazuhide Iizuka, Takashi Hamada, Takashi Koike, Kazuya Kurihara, Toshihide Endo, Tomohiro Nakayama, Yoshihiro Hatta, Hideki Nakamura
Clinical entity of cytomegalovirus disease in patients with malignant lymphoma on bendamustine therapy: a single-institution experience. Leukemia & lymphoma (2022)
Noriyoshi Iriyama
Chronic myeloid leukemia: the cutting-edge evidence and things we should know. International journal of hematology (2022)
Eriko Sato, Noriyoshi Iriyama, Michihide Tokuhira, Tomoiku Takaku, Maho Ishikawa, Tomonori Nakazato, Kei-Ji Sugimoto, Hiroyuki Fujita, Yuta Kimura, Isao Fujioka, Norio Asou, Norio Komatsu, Masahiro Kizaki, Yoshihiro Hatta, Tatsuya Kawaguchi
The EUTOS long-term survival score predicts disease-specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice-based cohort. Cancer medicine 9 (23) (2020)
Kazuya Kurihara, Noriyoshi Iriyama, Katsuhiro Miura, Yoshihito Uchino, Hiromichi Takahashi, Masaru Nakagawa, Kazuhide Iizuka, Takashi Hamada, Takashi Koike, Yoshihiro Hatta, Tomohiro Nakayama, Masami Takei
MPC-1 expression in myeloma cells is associated with the efficacy of bortezomib therapy. Medical oncology (Northwood, London, England) 36 (9) (2019)
Noriyoshi Iriyama, Hiromichi Takahashi, Hiromu Naruse, Katsuhiro Miura, Yoshihito Uchino, Masaru Nakagawa, Kazuhide Iizuka, Takashi Hamada, Yoshihiro Hatta, Tomohiro Nakayama, Masami Takei
A novel fusion gene involving PDGFRB and GCC2 in a chronic eosinophilic leukemia patient harboring t(2;5)(q37;q31). Molecular genetics & genomic medicine 7 (4) (2019)
Noriyoshi Iriyama, Michihide Tokuhira, Eriko Sato, Kei-Ji Sugimoto, Tomoiku Takaku, Maho Ishikawa, Tomonori Nakazato, Hiroyuki Fujita, Yuta Kimura, Isao Fujioka, Norio Asou, Norio Komatsu, Masahiro Kizaki, Yoshihiro Hatta, Tatsuya Kawaguchi
Smoking influences the outcomes of patients receiving tyrosine kinase inhibitors for chronic myeloid leukemia in the chronic phase: A retrospective analysis. Hematological oncology 37 (3) (2019)
Noriyoshi Iriyama, Kei-Ji Sugimoto, Eriko Sato, Tomoiku Takaku, Michihide Tokuhira, Tomonori Nakazato, Maho Ishikawa, Hiroyuki Fujita, Isao Fujioka, Yuta Kimura, Norio Asou, Masahiro Kizaki, Norio Komatsu, Yoshihiro Hatta, Tatsuya Kawaguchi
Comparison of the clinical outcomes of nilotinib and dasatinib therapies in newly diagnosed patients in the chronic phase of chronic myeloid leukemia: a retrospective analysis. Medical oncology (Northwood, London, England) 35 (11) (2018)